Ac-KVPL-CMK (TFA)
Ac-KVPL-CMK TFA is the trifluoroacetic acid of Ac-KVPL-CMK. Ac-KVPL-CMK is an inhibitor that specifically targets Granzyme M (GrM). Ac-KVPL-CMK significantly inhibits GrM-mediated tumor cell death. Ac-KVPL-CMK reduces the cytotoxic activity of LAK cells against HeLa cells. Ac-KVPL-CMK can be used for the study of cancer[1].
Product Specifications
UNSPSC
12352005
Target
Others
Related Pathways
Others
Field of Research
Cancer
Purity
98.10
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
NCCCC[C@H](NC(C)=O)C(N[C@@H](C(C)C)C(N1[C@@H](CCC1)C(N[C@@H](CC(C)C)C(CCl)=O)=O)=O)=O.O=C(O)C(F)(F)F.[x]
Molecular Formula
C25H44ClN5O5.xC2HF3O2
Molecular Weight
530.10 (free base)
References & Citations
[1]de Poot SA, et al. Granzyme M: behind enemy lines. Cell Death Differ. 2014 Mar;21 (3) :359-68.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Human AMDHD2 Protein - (Dry Ice)
Rabbit anti-Escherichia coli (strain K12) gmhA Polyclonal Antibody
Slc18a2 sgRNA CRISPR Lentivector (Mouse) (Target 1)
